Regulatory Sports Medicine Organogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu® for Knee Osteoarthritis Pain byTim AllenDecember 15, 2025
Biologics Sports Medicine Organogenesis Provides Update on Second Phase 3 ReNu® Study byTim AllenSeptember 26, 2025
Biologics Regulatory Sports Medicine Organogenesis ReNu® Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation For Osteoarthritis of the Knee byJosh SandbergJanuary 11, 2021
